Reggie Y C Lo

Title: Reggie Y C Lo: Innovator in Modified Leukotoxin Research

Introduction

Reggie Y C Lo is a notable inventor based in Guelph, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of modified leukotoxin proteins. With a total of 3 patents to his name, his work has implications for vaccine development in animals.

Latest Patents

Reggie Y C Lo's latest patents focus on modified leukotoxin proteins. One of his inventions provides nucleic acid sequences encoding a modified leukotoxin protein, which involves the removal of nucleic acid sequences that encode amino acids within hydrophobic transmembrane domains of the full-length leukotoxin protein. These modified leukotoxin proteins are designed to be useful in vaccine compositions that are effective against diseases in animals.

Career Highlights

Throughout his career, Reggie has worked at the University of Guelph, where he has been involved in groundbreaking research. His innovative approach to modifying leukotoxin proteins has positioned him as a key figure in the field of veterinary vaccine development.

Collaborations

Reggie has collaborated with notable colleagues such as Patricia E Shewen and Raymond W H Lee. Their combined expertise has contributed to the advancement of research in the area of modified leukotoxin proteins.

Conclusion

Reggie Y C Lo's work in the field of biotechnology, particularly with modified leukotoxin proteins, showcases his innovative spirit and dedication to improving animal health through vaccine development. His contributions are significant and continue to influence the scientific community.